ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class: |
Trading Symbol(s) |
Name of Each Exchange on Which Registered: | ||
one-fifth of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Auditor Firm ID: |
Auditor Name: |
Auditor Location: |
• | “amended and restated memorandum and article of association” are to the amended and restated memorandum and articles of association of the Company, adopted and filed on March 4, 2021. |
• | “Companies Law” are to the Companies Act (2021 Revision) of the Cayman Islands as the same may be amended from time to time; |
• | “founder shares” are to our Class B ordinary shares initially issued to our sponsor in a private placement prior to our initial public offering and the Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof (for the avoidance of doubt, such Class A ordinary shares will not be “public shares”); |
• | “initial shareholders” refers to all of our shareholders immediately prior to the Effective Date of our initial public offering, including all of our officers and directors to the extent they hold such shares; |
• | “management” or our “management team” are to our executive officers and directors; |
• | “NYSE” are to the New York Stock Exchange; |
• | “ordinary shares” are to our Class A ordinary shares and our Class B ordinary shares; |
• | “private placement warrants” are to the warrants sold to our sponsor as part of a private placement units simultaneously with the closing our initial public offering and upon conversion of working capital loans, if any; |
• | “public shares” are to our Class A ordinary shares sold as part of the units in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market); |
• | “public shareholders” are to the holders of our public shares, including our sponsor and management team to the extent our sponsor and/or members of our management team purchase public shares, provided that our sponsor’s and each member of our management team’s status as a “public shareholder” will only exist with respect to such public shares; |
• | “public warrants” are to our redeemable warrants sold as part of the units in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market); |
• | “SEC” are to the Securities and Exchange Commission; |
• | “Warburg Pincus I—B” are to Warburg Pincus Capital Corporation I—B, a Cayman Islands exempted company and blank check company formed for substantially similar purposes as our company; |
• | “sponsor” are to Warburg Pincus Capital Corporation I—A Sponsor, L.P., a Cayman Islands exempted limited partnership; |
• | “warrants” are to our redeemable warrants, which includes the public warrants as well as the private placement warrants to the extent they are no longer held by the initial purchasers of the private placement warrants or their permitted transferees; and |
• | “we,” “us,” “our,” “company” or “our company” are to Warburg Pincus Capital Corporation I—A, a Cayman Islands exempted company. |
• | our ability to complete our initial business combination; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | the ability of our officers and directors to generate a number of potential acquisition opportunities; |
• | our pool of prospective target businesses; |
• | the ability of our officers and directors to generate a number of potential acquisition opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or |
• | our financial performance. |
Item 1. |
Business. |
• | “One-Firm” Approach that Creates Alignment: “One-Firm” culture that remains a private partnership. Professionals are incentivized by the performance of all of the firm’s investments as a whole, rather than being incentivized by the performance of investments under each professionals’ responsibility. The firm’s incentive structure for investment professionals, policy of not charging deal fees, service fees or transaction fees and the significant sponsor commitment to the firm’s funds all reinforce Warburg Pincus’ “One-Firm” culture. |
• | Deal Sourcing Driven by Warburg Pincus’ Vast Global Network : |
• | Global, Sector-Focused, Thesis-Driven, Growth Investor at Scale : sub-sectors. Additionally, the firm has the flexibility to invest across stage of life of a company, from early-stage, to growth-stage and including more later-stage buyouts, where growth still remains a key part of the investment thesis. Consistent with the flexibility in stage of investment, the firm and its substantial AUM has a long history of making a wide range of investment sizes. |
• | Growth-Oriented Investing to Achieve Long-Term Fundamental Value Creation : start-up companies, to providing capital to meet the needs of existing businesses, to investing in later-stage buyouts, typically in circumstances in which growth is a key aspect of the investment thesis. Over the years, Warburg Pincus has invested in growth companies (approximately 50%-60% of capital invested) as well as companies at other stages of development including building early-stage and start-up companies (approximately 20%-25% of capital invested) and investing in later-stage buyout transactions and special situations (approximately 20%-25% of capital invested). Growth is a key aspect of the investment thesis. With the focus on investing in growth companies, the firm’s investments have the potential to deliver high levels of top-line and bottom-line growth for extended periods of time, permitting the firm to hold investments longer and to focus on managing toward an attractive multiple as well as an attractive IRR. We think this investment experience is well-positioned for application to the types of investments the company will pursue. |
• | Long History of Control and Non-Control Investing Brings Deep Experience in Structuring: |
• | are leading companies that have historically demonstrated positive organic revenue growth and/or are experiencing secular tailwinds; |
• | have the near-term potential to generate strong free cash flow; |
• | have long-term growth and scalability prospects through implementation of operational efficiencies, funding of key products, geographic expansion and/or M&A opportunities; |
• | can benefit from our management team and Warburg Pincus’ operating expertise, vast industry network and financing experience; |
• | are at the point in their lifecycle at which they have surpassed material proof-of-concept |
• | align with our top-down geographic and industry-specific themes and core theses; |
• | are led by accomplished management teams who are eager and ready to be part of a public company and will maintain meaningful economic stakes alongside us; and |
• | will offer an attractive risk-adjusted return for our shareholders. |
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
• | we issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary shares then-outstanding (other than in a public offering); |
• | any of our directors, officers or substantial security holder (as defined by the NYSE rules) has a 5% or greater interest, directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in issued and outstanding ordinary shares or voting power of 1% or more (or 5% or more if the related party involved is classified as such solely because such person is a substantial security holder); or |
• | the issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
• | the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company; |
• | the expected cost of holding a shareholder vote; |
• | the risk that the shareholders would fail to approve the proposed business combination; |
• | other time and budget constraints of the company; and |
• | additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
• | file proxy materials with the SEC. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
Item 1A. |
Risk Factors. |
• | We are a recently incorporated company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
• | Past performance by Warburg Pincus, our management team or their respective affiliates may not be indicative of future performance of an investment in us. |
• | Our shareholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our shareholders do not support such a combination. |
• | Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash. |
• | If we seek shareholder approval of our initial business combination, our sponsor and members of our management team have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote. |
• | The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target. |
• | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure. |
• | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares. |
• | The requirement that we consummate an initial business combination within 24 months after the closing of our initial public offering may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders. |
• | Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the coronavirus (“COVID-19”) outbreak and the status of debt and equity markets. |
• | We may not be able to consummate an initial business combination within 24 months after the closing of our initial public offering, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate. |
• | If we seek shareholder approval of our initial business combination, our sponsor, directors, executive officers, advisors and their affiliates may elect to purchase public shares or warrants, which may influence a vote on a proposed business combination and reduce the public “float” of our Class A ordinary shares or public warrants. |
• | Certain of our officers and directors have or will have direct and indirect economic interests in us and/or our sponsor after the consummation of our initial public offering and such interests may potentially conflict with those of our public shareholders as we evaluate and decide whether to recommend a potential business combination to our public shareholders. |
• | If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed. |
• | You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. |
• | NYSE may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
• | You will not be entitled to protections normally afforded to investors of many other blank check companies. |
• | If we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of shareholders are deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability to redeem all such shares in excess of 15% of our Class A ordinary shares. |
• | Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless. |
• | If the net proceeds of our initial public offering and the sale of the private placement warrants not being held in the trust account are insufficient to allow us to operate for the 24 months following the closing of our initial public offering, it could limit the amount available to fund our search for a target business or businesses and our ability to complete our initial business combination, and we will depend on loans from our sponsor, its affiliates or members of our management team to fund our search and to complete our initial business combination. |
• | We have identified a material weakness in our internal control over financial reporting (See our Amended Quarterly Report on Form 10-Q for the period ended September 30, 2021 filed with the SEC on January 18, 2022). |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, |
• | registration as an investment company with the SEC; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | may significantly dilute the equity interest of investors in our initial public offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
• | we have a board that includes a majority of “independent directors,” as defined under the rules of the NYSE; |
• | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
• | we have a nominating and corporate governance committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. |
• | costs and difficulties inherent in managing cross-border business operations; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, crime, strikes, riots and civil disturbances; |
• | regime changes and political upheaval; |
• | terrorist attacks, natural disasters and wars; and |
• | deterioration of political relations with the United States. |
Item 1B. |
Unresolved Staff Comments. |
Item 2. |
Properties. |
Item 3. |
Legal Proceedings. |
Item 4. |
Mine Safety Disclosures. |
Item 5. |
Market for Registrant’s Common Equity, Related Shareholder Matters, and Issuer Purchases of Equity Securities. |
Item 6. |
Selected Financial Data. |
Item 7. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
Item 7A. |
Quantitative and Qualitative Disclosures about Market Risk. |
Item 8. |
Financial Statements and Supplementary Data. |
Item 9. |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. |
Item 9A. |
Controls and Procedures. |
Item 9B. |
Other Information. |
Item 9C. |
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. |
Item 10. |
Directors, Executive Officers and Corporate Governance |
Name |
Age |
Position | ||||
Christopher H. Turner |
58 | Chairman and Chief Executive Officer | ||||
Tara O’Neill |
48 | Chief Financial Officer and Director | ||||
Mark Colodny |
54 | Director | ||||
James Neary |
57 | Director | ||||
Anesa Chaibi |
55 | Director | ||||
Alison Rand |
54 | Director | ||||
Timothy J. Curt |
58 | Director |
• | meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; |
• | monitoring the independence of the independent registered public accounting firm; |
• | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |
• | inquiring and discussing with management our compliance with applicable laws and regulations; |
• | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
• | appointing or replacing the independent registered public accounting firm; |
• | determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent registered public accounting firm regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; |
• | monitoring compliance on a quarterly basis with the terms of our initial public offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of our initial public offering; and |
• | reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors, with the interested director or directors abstaining from such review and approval. |
• | should have demonstrated notable or significant achievements in business, education or public service; |
• | should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and |
• | should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s and Chief Financial Officer’s, evaluating our Chief Executive Officer’s and Chief Financial Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer and Chief Financial Officer based on such evaluation; |
• | reviewing and approving the compensation of all of our other Section 16 executive officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and/or annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement, to the extent required; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
• | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
• | directors should not improperly fetter the exercise of future discretion; |
• | duty to exercise powers fairly as between different sections of shareholders; |
• | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
• | duty to exercise independent judgment. |
Individual |
Entity |
Entity’s Business |
Affiliation | |||
Christopher H. Turner | Warburg Pincus LLC (1) |
Private Equity | Managing Director | |||
Warburg Pincus Capital Corporation I—B |
Special Purpose Acquisition Company |
Chairman and Chief Executive Officer | ||||
Tara O’Neill | Warburg Pincus LLC (1) |
Private Equity | Senior Vice President | |||
Warburg Pincus Capital Corporation I—B |
Special Purpose Acquisition Company |
Chief Financial Officer and Director | ||||
Mark Colodny | Warburg Pincus LLC (1) |
Private Equity | Managing Director, Co- Head of U.S. Private Equity | |||
Warburg Pincus Capital Corporation I—B |
Special Purpose Acquisition Company |
Director | ||||
HElix Opco, LLC | Genomics Company | Director | ||||
ProPublica | Non-Profit Organization |
Director | ||||
The City | Non-Profit Organization |
Director | ||||
Council on Foreign Relations | Think Tank | Member |
James Neary | Warburg Pincus LLC (1) |
Private Equity | Managing Director, Co- Head of U.S.Private Equity | |||
Warburg Pincus Capital Corporation I—B |
Special Purpose Acquisition Company |
Director | ||||
Allied Universal | Security Company | Director | ||||
Consolidated Precision Products | Manufacturing | Director | ||||
Duravant | Manufacturing | Director | ||||
Endurance International Group | IT Service Management | Director | ||||
Hygiena | Healthcare | Director | ||||
Sotera Health | Healthcare | Director | ||||
Wex | IT Service Management | Director | ||||
Mount Sinai Health Systems | Healthcare | Trustee | ||||
The Eaglebrook School | Education | Trustee | ||||
Anesa Chaibi | Warburg Pincus LLC (1) |
Private Equity | Industry Advisor | |||
Regal Beloit Corporation | Manufacturing | Director | ||||
Advanced Drainage Systems | Manufacturer/Distributor | Director and member of Audit Committee | ||||
Alison Rand | Primerica | Financial Services | Executive Vice President and Chief Financial Officer | |||
University of Florida National Foundation |
Non-Profit Organization |
Chair of the Audit Committee and member of the Executive Committee | ||||
The University of Florida Warrington College of Business | Education | Member of the Dean’s Advisory Council | ||||
Junior Achievement of Georgia | Non-Profit Organization |
Member of Executive Committee of the Board of Directors | ||||
Timothy J. Curt | The University of Connecticut School of Business |
Education | Member of Dean’s Advisory Cabinet |
(1) | Includes its funds, their respective portfolio companies and other affiliates. |
• | Our officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses, on the other hand. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our executive officers and directors is engaged in several other business endeavors for which he is entitled to substantial compensation and has substantial time commitments, and our executive officers and directors are not obligated to contribute any specific number of hours per week to our affairs. |
• | Our sponsor subscribed for founder shares and purchased private placement warrants in a transaction that closed simultaneously with the closing of our initial public offering. |
• | Our sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination and (ii) a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares. |
Item 11. |
Executive Compensation |
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters |
• | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
• | each of our executive officers, directors and director nominees that beneficially owns ordinary shares; and |
• | all our executive officers, directors and director nominees as a group. |
Class A ordinary shares |
Class B ordinary shares |
Approximate Percentage of Ordinary Shares |
||||||||||||||||||
Name and Address of Beneficial Owner(1) |
Number of Shares Beneficially Owned |
Approximate Percentage of Class |
Number of Shares Beneficially Owned(2) |
Approximate Percentage of Class |
||||||||||||||||
Warburg Pincus Capital Corporation I—A Sponsor, L.P. (our sponsor)(3) |
— | — | 6,980,544 | 98.5 | % | 19.7 | % | |||||||||||||
Christopher H. Turner |
— | — | — | — | — | |||||||||||||||
Tara O’Neill |
— | — | — | — | — | |||||||||||||||
Mark Colodny |
— | — | — | — | — | |||||||||||||||
James Neary |
— | — | — | — | — | |||||||||||||||
Alison Rand |
— | — | 35,000 | * | * | |||||||||||||||
Anesa Chaibi |
— | — | 35,000 | * | * | |||||||||||||||
Timothy J. Curt |
— | — | 35,000 | * | * | |||||||||||||||
All officers, directors and director nominees as a group (seven individuals) |
— | — | 7,085,544 | 100.0 | % | 20.0 | % | |||||||||||||
Governors Lane LP(4) |
1,550,000 | 5.5 | % | — | — | 4.4 | % | |||||||||||||
Empyrean Capital Partners, LP(5) |
1,500,000 | 5.3 | % | — | — | 4.2 | % | |||||||||||||
Adage Capital Partners GP, L.L.C.(6) |
2,000,000 | 7.1 | % | — | — | 5.6 | % | |||||||||||||
Magnetar Financial LLC(7) |
1,491,733 | 5.3 | % | — | — | 4.2 | % |
* | Less than one percent |
(1) | Unless otherwise noted, the business address of each of our shareholders is 450 Lexington Avenue, New York, New York 10017. |
(2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described in the section entitled “Description of Securities.” |
(3) | The shares reported above are held in the name of our sponsor. Our sponsor is controlled by its ultimate general partner, Warburg Pincus Bermuda Private Equity GP LTD, which is governed by a three member board of directors. Each director has one vote, and the approval of a majority of the directors is required to approve an action of our sponsor. Under the so-called “rule of three,” if voting and dispositive decisions regarding an entity’s securities are made by two or more individuals, and a voting and dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity’s securities. This is the situation with regard to our sponsor. Based upon the foregoing analysis, no individual director of the general partner of our sponsor exercises voting or dispositive control over any of the securities held by our sponsor, even those in which such director directly holds a pecuniary interest. Accordingly, none of them will be deemed to have or share beneficial ownership of such shares. |
(4) | Based solely on the Schedule 13G filed by Governors Lane LP on March 19, 2021, (a) each of Governors Lane Master Fund LP, Governors Lane LP, Governors Lane Fund General Partner LLC and Isaac Corre has the shared voting power and the shared dispositive power with respect to 1,550,000 Class A ordinary shares, (b) Governors Lane LP serves as discretionary investment manager to Governors Lane Master Fund LP, (c) Governors Lane Fund General Partner LLC is the general partner of Governors Lane Master Fund LP, (d) Mr. Corre is the chief executive officer of Governors Lane LP and the managing member of Governors Lane Fund General Partner LLC and (e) the business address of each of the foregoing persons is 510 Madison Avenue, 11th Floor, New York, NY 10022. |
(5) | Based solely on the Schedule 13G filed by Empyrean Capital Partners, LP on March 19, 2021, (a) each of Empyrean Capital Overseas Master Fund, Ltd. (“ECOMF”), Empyrean Capital Partners, LP (“ECP”) and Amos Meron has the shared voting power and the shared dispositive power with respect to 1,500,000 Class A ordinary shares, (b) ECOMF directly holds these Class A ordinary shares, (c) ECP serves as investment manager to ECOMF with respect to the Class A ordinary shares directly held by ECOMF, (c) Mr. Amos Meron serves as the managing member of Empyrean Capital, LLC, the general partner of ECP, (d) the foregoing should not be construed in and of itself as an admission by any of the foregoing persons as to beneficial ownership of Class A ordinary shares owned by another person and (e) the business address of each of the foregoing persons is c/o Empyrean Capital Partners, LP, 10250 Constellation Boulevard, Suite 2950, Los Angeles, CA 90067. |
(6) | Based solely on the Schedule 13G filed by Adage Capital Partners GP, L.L.C. on March 19, 2021, (a) each of Adage Capital Partners, L.P. (“ACP”), Adage Capital Partners GP, L.L.C. (“ACPGP”), Adage Capital Advisors, L.L.C. (“ACA”), Robert Atchinson and Phillip Gross has the shared voting power and the shared dispositive power with respect to 2,000,000 Class A ordinary shares, (b) ACP directly holds these Class A ordinary shares, (c) ACPGP is the general partner of ACP, (d) ACA is the managing member of ACPGP, (e) Robert Atchinson is the managing member of ACA, (f) Phillip Gross is the managing member of ACA, (g) the foregoing should not be construed in and of itself as an admission by any of the foregoing persons as to beneficial ownership of these Class A ordinary shares and (h) the business address of each of the foregoing persons is 200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116. |
(7) | Based solely on the Schedule 13G filed by Magnetar Financial LLC on January 28, 2022, (a) each of Magnetar Financial LLC (“Magnetar Financial”), Magnetar Capital Partners LP (Magnetar Capital Partners”), Supernova Management LLC (“Supernova Management”) and Alec N. Litowitz has the shared voting power and the shared dispositive power with respect to 1,491,733 Class A ordinary shares, (b) the Schedule 13G relates to the Class A ordinary shares held for Magnetar Constellation Fund II, Ltd (“Constellation Fund II”), Magnetar Constellation Master Fund, Ltd (“Constellation Master Fund”), Magnetar Systematic Multi-Strategy Master Fund Ltd (“Systematic Master Fund”), Magnetar Capital Master Fund Ltd (“Master Fund”), Magnetar Discovery Master Fund Ltd (“Discovery Master Fund”), Magnetar Xing He Master Fund Ltd (“Xing He Master Fund”), Purpose Alternative Credit Fund Ltd (“Purpose Fund”), Magnetar SC Fund Ltd (“SC Fund”), Magnetar Structured Credit Fund, LP (“Structured Credit Fund”), Magnetar Lake Credit Fund LLC (“Lake Credit Fund”), Purpose Alternative Credit Fund—T LLC (“Purpose Fund—T”) (collectively, the “Magnetar Funds”), (c) Magnetar Financial serves as the investment adviser to the Magnetar Funds, and as such, Magnetar Financial exercises voting and investment power over the Class A ordinary shares held for the Magnetar Funds’ accounts, (d) Magnetar Capital Partners serves as the sole member and parent holding company of Magnetar Financial, (e) Supernova Management is the general partner of Magnetar Capital Partners, (f) the manager of Supernova Management is Alec N. Litowitz, (g) as of December 31, 2021, the amount consists of (i) 144,035 shares held for the account of Constellation Fund II; (ii) 496,395 shares held for the account of Constellation Master Fund; (iii) 141,000 shares held for the account of Systematic Master Fund; (iv) 49,906 shares held for the account of Master Fund; (v) 14,827 shares held for the account of Discovery Master Fund; (vi) 168,465 shares held for the account of Xing He Master Fund; (vii) 72,015 shares held for the account of Purpose Fund; (viii) 111,880 shares held for the account of SC Fund; (ix) 191,615 shares held for the account of Structured Credit Fund; (x) 77,160 shares held for the account of Lake Credit Fund; and (xi) 24,435 shares held of the account of Purpose Fund—T, and (h) the business address of each of Magnetar Financial, Magnetar Capital Partners, Supernova Management, and Alec N. Litowitz is 1603 Orrington Avenue, 13th Floor, Evanston, Illinois 60201. |
Item 13. |
Certain Relationships and Related Transactions, and Director Independence |
Item 14 . |
Principal Accountant Fees and Services. |
Item 15. |
Exhibits, Financial Statements and Financial Statement Schedules |
* | Filed herewith. |
** | Furnished herewith. |
(1) | Incorporated by reference to the registrant’s Registration Statement on Form S-1, filed with the SEC on March 2, 2021. |
(2) | Incorporated by reference to registrant’s Current Report on Form 8-K, filed with the SEC on March 9, 2021. |
Item 16. |
Form 10-K Summary |
F-2 |
||||
Financial Statements: |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 |
December 31, 2021 |
December 31, 2020 |
|||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | $ | — | |||||
Prepaid expenses |
||||||||
Total current assets |
||||||||
Deferred offering costs associated with initial public offering |
— | |||||||
Investments held in Trust Account |
||||||||
Total Assets |
$ |
$ |
||||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit): |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | — | |||||
Accrued expenses |
||||||||
Total current liabilities |
||||||||
Derivative warrant liabilities |
— | |||||||
Deferred underwriting commissions |
— | |||||||
Total liabilities |
||||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, $ - |
— | |||||||
Shareholders’ Equity (Deficit): |
||||||||
Preference shares, $ |
— | |||||||
Class A ordinary shares, $ non-redeemable shares issued or outstanding as of December 31, 2021 and 2020 |
— | |||||||
Class B ordinary shares, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total shareholders’ equity (deficit) |
( |
) | ||||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
||||||
For the Year Ended December 31, 2021 |
For the period from December 1, 2020 (inception) through December 31, 2020 |
|||||||
General and administrative expenses |
$ | $ | ||||||
General and administrative expenses - related party |
||||||||
|
|
|
|
|||||
Loss from operations |
( |
) | < |